CBP-CON-00177
Active
Federal
Octapharma Australia Pty Limited
Awarded by National Blood Authority
The National Blood Authority contracted Octapharma Australia Pty Limited for a national supply arrangement of imported immunoglobulin products valued at AU$329,670,000 from December 2020 to December 2027. The contract was awarded via limited tender under exemption TR — 10.3.d.iii due to an absence of competition for technical reasons, and has been amended twice.
$329.7M
Contract Value
Contract Details
- Reference
- CN3743079
- Jurisdiction
- Federal
- Financial Year
- FY26
- Category
- Drugs and Pharmaceutical(UNSPSC: 51000000)
Description
National Supply arrangement for imported immunoglobulin products
Key Dates
- Publish Date
- 18 June 2026
- Effective Date
- 31 Dec 2020
- End Date
- 30 Dec 2027
Published fields
- Procurement method
- Limited tender
- Location
- Not published in this source
Supplier
Octapharma Australia Pty Limited
- ABN
- 23 109 574 692
Agency
National Blood Authority
- ABN
- 87 361 602 478
Contract History
This contract has been amended 2 times.
Original Contract
Published 19 Jan 2021
$131.7M
Amendment A1
Published 18 June 2026
$214.4M
Amendment A2
Current
Published 18 June 2026
$329.7M